ArticleMicrobial cell factories2025
Identifying new targets for improving terpenoid biosynthesis in Yarrowia lipolytica through random genomic cytosine base editing.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 10 years of CRISPR/CAS genomic engineering in Yarrowia lipolytica.Bioprocess and biosystems engineering · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundGenome-scale mutagenesis integrated with high-throughput phenotypic screening and causal mutation mapping serves as a robust paradigm for systemic genetic dissection. Despite the application of non-homologous end joining (NHEJ)-mediated genome editing in Yarrowia lipolytica, the development of alternative genome-wide mutagenesis strategies remains unexplored in this industrially relevant oleaginous yeast.
resultsWe developed the Helicase-Assisted (Helicase-CDA) system, a genome-wide mutagenesis platform integrating the helicase domain of Yarrowia MCM5 (Encoded by YALI1_A01766g) with cytidine deaminase (CDA). This system enables continuous C-to-T specific mutations at random genomic loci. Applied to an industrial β-carotene-producing Y. lipolytica strain, Helicase-CDA system generated a mutagenized library through 7-day subculturing. Through high-throughput screening, we successfully isolated the mutant strain CDA-14, which demonstrated a 25% enhancement in β-carotene production (448.1 mg/L) compared to the wild-type strain. Notably, its productivity of β-carotene reached 6.15 g/L in fed-batch fermentation. Whole-genome sequencing revealed a G1637A substitution in YALI1_B16239g, which encodes a membrane protein showing homology to sterol biosynthesis regulator MGA2. This mutation led to reduced ERG1 expression level and redirected central carbon flux toward carotenoid synthesis by perturbing isoprenoid precursor partitioning.
conclusionHelicase-CDA system circumvents the dependency on NHEJ-mediated whole-genome mutation approach, offering a robust tool for continuous genome evolution in pre-engineered industrial strains. This study not only enhances genome editing in Y. lipolytica but also identifies a practical target for optimizing terpenoid biosynthesis, demonstrating significant potential for applications in metabolic engineering and synthetic biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.